Immunoreactivity of canine, feline, and equine D-dimer with antibodies to human D-dimer
Journal of Veterinary Internal Medicine · 01.01.2024 · 38 (1) · 187-196
DOI: 10.1111/jvim.16888 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, online erschienen am 01.01.2024. Verfasst von Juliet E Brown und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Fibrin Fibrinogen Degradation Products, Antibodies, Monoclonal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Society for Veterinary Clinical Pathology, EveryCat Health Foundation, University of Melbourne.
Abstract (Originalsprache)
Background
Commercially available D-dimer assays use antibodies against human D-dimer, with limited sensitivity and specificity data in companion animals.
Objectives
To evaluate the immunoreactivity of D-dimer in plasma of dogs, horses, and cats with commercially available antibodies to human D-dimer. Animals Plasma samples were collected from healthy dogs and horses, and from surplus feline plasma submitted for diagnostic purposes.
Methods
Descriptive research study. A cross-linked fibrin lysate was prepared from plasma samples, and SDS-PAGE and immunoblotting were performed with a variety of commercially available antibodies to human D-dimer.
Results
The selected antibodies demonstrated variable reactivity with D-dimer of each species. The monoclonal antibody DD44 bound canine D-dimer with good specificity and sensitivity, but this antibody did not react with feline or equine D-dimer. The polyclonal antibody D2D bound putative D-dimer in dogs, cats, and horses with good specificity, and higher sensitivity compared to human D-dimer. Conclusions and Clinical Importance The variable performance of commercially available human D-dimer assays between species is, in part, because of inter-species variation in D-dimer immunoreactivity. The use of these assays should follow validation studies. Monoclonal antibody DD44 could be a focus for the development of a canine-specific assay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Juliet E Brown
Förderung
- American Society for Veterinary Clinical Pathology
- EveryCat Health Foundation
- University of Melbourne
Zitieren
APA
Brown, J. E., Noormohammadi, A. H., & Courtman, N. F. (2024). Immunoreactivity of canine, feline, and equine D-dimer with antibodies to human D-dimer. Journal of Veterinary Internal Medicine, 38(1), 187-196. https://doi.org/10.1111/jvim.16888
Vancouver
Brown JE, Noormohammadi AH, Courtman NF. Immunoreactivity of canine, feline, and equine D-dimer with antibodies to human D-dimer. Journal of Veterinary Internal Medicine. 2024;38(1):187-196. doi:10.1111/jvim.16888
BibTeX
@article{Brown2024,
author = {Brown, Juliet E and Noormohammadi, Amir H and Courtman, Natalie F},
title = {Immunoreactivity of canine, feline, and equine D-dimer with antibodies to human D-dimer},
journal = {Journal of Veterinary Internal Medicine},
year = {2024},
volume = {38},
number = {1},
pages = {187--196},
doi = {10.1111/jvim.16888}
}
EUVIMED